Related Experiment Videos
Does clofazimine have a prophylactic role against neuritis?
1Schieffelin Leprosy Research and Training Centre (SLR&TC), Tamil Nadu, India.
Leprosy Review
|November 19, 1997
Summary
Clofazimine shows promise in preventing neuritis and nerve damage in high-risk leprosy patients. A modified regimen significantly reduced neuritis incidence compared to standard multidrug therapy alone.
Area of Science:
- Medical Research
- Infectious Diseases
- Neurology
Background:
- Leprosy can cause debilitating neuritis and nerve damage.
- Standard multidrug therapy (MB-MDT) may not fully prevent these complications.
- Clofazimine is an established treatment for leprosy.
Purpose of the Study:
- To evaluate clofazimine's prophylactic efficacy against neuritis and nerve damage in high-risk borderline leprosy patients.
- To compare outcomes between a modified clofazimine regimen and standard MB-MDT.
Main Methods:
- A modified regimen with initial high-dose clofazimine followed by MB-MDT was administered to 65 high-risk leprosy patients.
- A control group of 57 patients received only MB-MDT.
- Incidence of neuritis/Type I reaction was monitored over 2 years.
Main Results:
- The group receiving the modified clofazimine regimen exhibited a significantly lower incidence of neuritis/Type I reaction (p < 0.01).
- This suggests a protective effect of clofazimine against nerve complications.
Conclusions:
- Clofazimine, when used in a modified regimen, appears to be an effective prophylactic agent against neuritis and nerve damage in leprosy.
- This finding supports the potential integration of clofazimine for nerve damage prevention in leprosy management.